UNSPSC 51283726: Cefuroxime sodium

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R8A7M9MY61. European Medicines Agency schedules Cefuroxime sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01140MIG. Cefuroxime sodium generally arises in the molecular formula C16H15N4NAO8S. The term 'cefuroxime sodium' is a U.S. Pharmacopeial Convention designation. Most nations, for tariff and trade purposes, schedule cefuroxime sodium under HS 29419000 and SITC 54139.

As of Q4 2014, CEFUROXIME SODIUM remains US FDA's Preferred Term for this commodity. Cefuroxime sodium bears US NLM identifiers UMLS ID C0701852 and NCI Concept Code C47439. SMILES: CO/N=C(/C1CCCO1)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-].[NA+].

UNSPSC 51283726 Cefuroxime sodium, a Commodity code, does not align with recent state and local procurement activity posted under this classification. The four opportunities tagged to this code involve naloxone and drug deactivation systems, direct-to-manufacturer pharmaceutical programs, medical and first aid supplies for fire rescue operations, and generic multi-source pharmaceuticals and OTC products—none of which specifically reference cefuroxime sodium or match the narrow scope of a single antibiotic compound. The mismatch suggests either a tagging error in the source data or that state and local procurement offices are using this code expansively to cover broader pharmaceutical purchasing when the code's nominal scope is a discrete pharmaceutical product.

Activity under this code across recent opportunities spans state health departments, county health systems, municipal fire rescue divisions, and multistate cooperative purchasing alliances. The issuing bodies include the Texas Health and Human Services Commission, Seminole County (Florida), the City of Tampa, and the Minnesota Department of Administration on behalf of MMCAP participating jurisdictions. Recent solicitations include Seminole County's IFB for naloxone and drug deactivation systems (due July 26, 2023), the City of Tampa's ITB for medical and first aid supplies for fire rescue (due March 13, 2026, estimated $700,000.00), Texas HHS's RFI on direct-to-manufacturer prescriptions (due April 3, 2026), and MMCAP's RFP for generic pharmaceuticals and OTC products across Minnesota and Oregon (proposals due March 26, 2026). Geographic activity appears concentrated in Florida, Texas, and the Upper Midwest, though the MMCAP solicitation extends to Oregon. No opportunities in the block specifically procure cefuroxime sodium or demonstrate sustained purchasing velocity under the code's stated commodity name.